Myron Czuczman, MD

Myron S. Czuczman, MD, is a hematologist-oncologist and physician-scientist whose work has focused on lymphoma and other blood cancers. He practiced for more than two decades at Roswell Park Comprehensive Cancer Center, where he served as chief of the Lymphoma/Myeloma Service and head of the Lymphoma Translational Research Laboratory, after fellowship training in medical oncology/hematology at Memorial Sloan Kettering Cancer Center. His research background includes early antibody-based lymphoma treatment work; Roswell Park notes that he initiated the first trial combining Rituxan with CHOP for non-Hodgkin lymphoma. He later led lymphoma/CLL clinical research at Celgene and is now chief medical officer at Citius Pharmaceuticals.